Skip to main content
Clinical Trials/NCT02039752
NCT02039752
Recruiting
Not Applicable

Asan Medical Center Registry for Multivessel

Seung-Jung Park1 site in 1 country25,000 target enrollmentMarch 1, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Seung-Jung Park
Enrollment
25000
Locations
1
Primary Endpoint
composite event
Status
Recruiting
Last Updated
4 months ago

Overview

Brief Summary

The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.

Registry
clinicaltrials.gov
Start Date
March 1, 2014
End Date
December 1, 2030
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Seung-Jung Park
Responsible Party
Sponsor Investigator
Principal Investigator

Seung-Jung Park

MD,PhD

Asan Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patients with multivessel disease from 1995 in Asan Medical Center
  • Age 19 and more

Exclusion Criteria

  • For prospective cohort, not agreeing to participate with written informed consent form

Outcomes

Primary Outcomes

composite event

Time Frame: 1year

death, myocardial infarction, stroke, revascularization

Secondary Outcomes

  • Bleeding(1year)
  • Myocardial Infarction(1year)
  • Revascularization(1year)
  • Re-hospitalization(1year)
  • Death(1year)
  • Stroke(1year)
  • Angina symptom(1year)
  • Stent thrombosis(1year)

Study Sites (1)

Loading locations...

Similar Trials